TRAF6 and cardiovascular disorder: Direct inhibition of the C‐terminal domain of TRAF6 (the TRAF‐C Meprin and TRAF Homology—or MATH—domain) has been proposed and explored as a potential therapeutic strategy for the treatment of a variety of pathologies such as cardiovascular diseases, diseases associated with obesity, osteoporosis, and others.12, 13, 14, 15, 16, 17, 18